Liothyronine Sodium Injection, Solution
Product Images NDC 39822-0151

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 39822-0151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\documents And Settings\junem.x-gen.000\desktop\lio Spl\fda Style Sheets\01.jpg (Liothyronine Sodium Injection 1)

C:\documents And Settings\junem.x-gen.000\desktop\lio Spl\fda Style Sheets\01.jpg (Liothyronine Sodium Injection 1)
Liothyronine Sodium is a compound with the chemical formula C\H,J,NNaO and a molecular weight of 672.96. Its primary ingredients include L-Tyrosine and O+(4-hydroxy-3-lodophenyl)-3,5-dliodo- monosodium salt.*
FDA Label Image

D2b1860a-figure-02 (Liothyronine Sodium Injection 2)

FDA Label Image

D2b1860a-figure-03 (Liothyronine Sodium Injection 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.